Kirsten I. Taylor
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Smartphone-derived digital motor measures to monitor progression in idiopathic REM sleep behavior disorder.
Journal: NPJ Parkinson's disease
Published: March 28, 2026
Case Series of Reconstruction Applying NovoSorb Biodegradable Temporising Matrix: Preliminary Practice and Findings in the United Kingdom.
Journal: Eplasty
Published: July 15, 2025
A Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of intravenous prasinezumab in early-stage Parkinson's disease (PADOVA): Rationale, design, and baseline data.
Journal: Parkinsonism & related disorders
Published: November 02, 2024
Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson's disease.
Journal: Nature medicine
Published: June 30, 2023
Trial of Prasinezumab in Early-Stage Parkinson's Disease.
Journal: The New England journal of medicine
Published: August 03, 2022
Hoehn and Yahr Stage and Striatal Dat-SPECT Uptake Are Predictors of Parkinson's Disease Motor Progression.
Journal: Frontiers in neuroscience
Published: August 27, 2021
Self-Report versus Clinician Examination in Early Parkinson's Disease.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: August 17, 2021
The perils of dressings: a cautionary tale of ischaemia.
Journal: Journal of wound care
Published: May 12, 2021
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data.
Journal: Frontiers in neurology
Published: May 05, 2021
Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: September 15, 2020
Last Updated: 09/26/2026